carbostyril has been researched along with Elevated ICP (Intracranial Pressure) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aylward, SC; Jordan, CO; Kopp, BT; Paul, GR; Wisniewski, BL | 1 |
| Aujard, Y; Bedu, A; Brisse, H; Farnoux, C; Le Huidoux, P; Naar, I | 1 |
2 other study(ies) available for carbostyril and Elevated ICP (Intracranial Pressure)
| Article | Year |
|---|---|
Hypervitaminosis A with fulminant secondary intracranial hypertension following personalized medicine-based Elexacaftor/Tezacaftor/Ivacaftor initiation in a preadolescent with cystic fibrosis.
Topics: Aminophenols; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Humans; Hypervitaminosis A; Indoles; Intracranial Hypertension; Precision Medicine; Pyrazoles; Pyridines; Pyrrolidines; Quinolones | 2022 |
[Intracranial hypertension in a newborn treated with quinolone].
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Bacteremia; Ceftazidime; Child; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Infant, Newborn; Infant, Premature; Intracranial Hypertension; Male; Parenteral Nutrition; Pefloxacin; Quinolones; Remission, Spontaneous | 1998 |